255 related articles for article (PubMed ID: 12235206)
21. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244
[TBL] [Abstract][Full Text] [Related]
22. CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation.
Jeltsch M; Jha SK; Tvorogov D; Anisimov A; Leppänen VM; Holopainen T; Kivelä R; Ortega S; Kärpanen T; Alitalo K
Circulation; 2014 May; 129(19):1962-71. PubMed ID: 24552833
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor C induces angiogenesis in vivo.
Cao Y; Linden P; Farnebo J; Cao R; Eriksson A; Kumar V; Qi JH; Claesson-Welsh L; Alitalo K
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14389-94. PubMed ID: 9826710
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo.
Byzova TV; Goldman CK; Jankau J; Chen J; Cabrera G; Achen MG; Stacker SA; Carnevale KA; Siemionow M; Deitcher SR; DiCorleto PE
Blood; 2002 Jun; 99(12):4434-42. PubMed ID: 12036873
[TBL] [Abstract][Full Text] [Related]
25. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.
Jeltsch M; Kaipainen A; Joukov V; Meng X; Lakso M; Rauvala H; Swartz M; Fukumura D; Jain RK; Alitalo K
Science; 1997 May; 276(5317):1423-5. PubMed ID: 9162011
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms of lymphangiogenesis in health and disease.
Alitalo K; Carmeliet P
Cancer Cell; 2002 Apr; 1(3):219-27. PubMed ID: 12086857
[TBL] [Abstract][Full Text] [Related]
27. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development.
Kukk E; Lymboussaki A; Taira S; Kaipainen A; Jeltsch M; Joukov V; Alitalo K
Development; 1996 Dec; 122(12):3829-37. PubMed ID: 9012504
[TBL] [Abstract][Full Text] [Related]
28. The formation of lymphatic vessels and its importance in the setting of malignancy.
Detmar M; Hirakawa S
J Exp Med; 2002 Sep; 196(6):713-8. PubMed ID: 12235205
[No Abstract] [Full Text] [Related]
29. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
Partanen TA; Paavonen K
Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
[TBL] [Abstract][Full Text] [Related]
30. VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis.
Hamada K; Oike Y; Takakura N; Ito Y; Jussila L; Dumont DJ; Alitalo K; Suda T
Blood; 2000 Dec; 96(12):3793-800. PubMed ID: 11090062
[TBL] [Abstract][Full Text] [Related]
31. Lymph node transfer and perinodal lymphatic growth factor treatment for lymphedema.
Honkonen KM; Visuri MT; Tervala TV; Halonen PJ; Koivisto M; Lähteenvuo MT; Alitalo KK; Ylä-Herttuala S; Saaristo AM
Ann Surg; 2013 May; 257(5):961-7. PubMed ID: 23013803
[TBL] [Abstract][Full Text] [Related]
32. [Lymphangiogenesis and biological activity ov vascular endothelial growth factor-C].
Mandriota SJ; Pepper MS
J Soc Biol; 1999; 193(2):159-63. PubMed ID: 10451350
[TBL] [Abstract][Full Text] [Related]
33. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D.
McColl BK; Baldwin ME; Roufail S; Freeman C; Moritz RL; Simpson RJ; Alitalo K; Stacker SA; Achen MG
J Exp Med; 2003 Sep; 198(6):863-8. PubMed ID: 12963694
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion.
Salven P; Hattori K; Heissig B; Rafii S
FASEB J; 2002 Sep; 16(11):1471-3. PubMed ID: 12205052
[TBL] [Abstract][Full Text] [Related]
35. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis.
Mimura T; Amano S; Usui T; Kaji Y; Oshika T; Ishii Y
Exp Eye Res; 2001 Jan; 72(1):71-8. PubMed ID: 11133184
[TBL] [Abstract][Full Text] [Related]
36. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.
Kubo H; Cao R; Brakenhielm E; Mäkinen T; Cao Y; Alitalo K
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8868-73. PubMed ID: 12070340
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal shock wave therapy combined with vascular endothelial growth factor-C hydrogel for lymphangiogenesis.
Kim IG; Lee JY; Lee DS; Kwon JY; Hwang JH
J Vasc Res; 2013; 50(2):124-33. PubMed ID: 23208012
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.
Witzenbichler B; Asahara T; Murohara T; Silver M; Spyridopoulos I; Magner M; Principe N; Kearney M; Hu JS; Isner JM
Am J Pathol; 1998 Aug; 153(2):381-94. PubMed ID: 9708799
[TBL] [Abstract][Full Text] [Related]
39. Stimulation and Inhibition of Lymphangiogenesis Via Adeno-Associated Viral Gene Delivery.
Karaman S; Nurmi H; Antila S; Alitalo K
Methods Mol Biol; 2018; 1846():291-300. PubMed ID: 30242767
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: immunohistochemical and molecular characterization.
Jin DP; An A; Liu J; Nakamura K; Rockson SG
Lymphat Res Biol; 2009; 7(1):47-57. PubMed ID: 19302023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
